Section Arrow
BBNX.NASDAQ
- Beta Bionics Inc
Quotes are at least 15-min delayed:2026/03/09 15:40 EDT
Regular Hours
Last
 10.56
-0.05 (-0.47%)
Day High 
10.67 
Prev. Close
10.61 
1-M High
15.53 
Volume 
1.03M 
Bid
10.55
Ask
10.57
Day Low
10.055 
Open
10.395 
1-M Low
10.44 
Market Cap 
470.89M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.29 
20-SMA 13.05 
50-SMA 18.15 
52-W High 32.71 
52-W Low 8.89 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.81/--
Enterprise Value
476.26M
Balance Sheet
Book Value Per Share
6.48
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
100.25M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.52+2.96+2.70%29.21PE
MDTMedtronic plc91.245+0.345+0.38%25.39PE
BSXBoston Scientific Corp72.155+0.805+1.13%36.78PE
BFLYButterfly Network3.8001+0.1501+4.11%-- 
PACBPacific Biosciences of California1.375-0.005-0.36%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and saleof the iLet.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.